Feb. 10 at 9:36 PM
$RGNT a shame the CFO hire and promoting in Europe pharma market didn't at least stop the decline to trade sideways. Just constant down at the moment.
Going to cut losses here and come back at 2-3 range.
Maybe everyone is expecting the next move is a share offering